Retransplantation in Greece: Ethical and practical considerations
Hellenic J Cardiol. 2023 Jul 8:S1109-9666(23)00114-8. doi: 10.1016/j.hjc.2023.07.002. Online ahead of print.NO ABSTRACTPMID:37429504 | DOI:10.1016/j.hjc.2023.07.002 (Source: Hellenic Journal of Cardiology)
Source: Hellenic Journal of Cardiology - July 10, 2023 Category: Cardiology Authors: Evangelos Leontiadis Nektarios Kogerakis Angeliki Gkouziouta Socrates Fragoulis Areti Falara Dimitrios Zarkalis Loukas Tsourelis Michael Bonios Loukas Kaklamanis Dimitrios Degiannis Themistoklis Chamogeorgakis Theofani Antoniou Stamatis Adamopoulos Source Type: research
Chlorthalidone versus hydrochlorothiazide for preventing cardiovascular disease in hypertension: Is the case closed?
Hellenic J Cardiol. 2023 Jul 8:S1109-9666(23)00115-X. doi: 10.1016/j.hjc.2023.07.003. Online ahead of print.ABSTRACTThe optimal diuretic choice [hydrochlorothiazide (HCTZ) or chlorthalidone (CTD)] for the management of hypertension has been an ongoing debate for several years. HCTZ is widely used in the form of single-pill combinations, whereas CTD is a more potent drug vs. HCTZ, especially in reducing nighttime blood pressure (BP), with some indirect evidence suggesting a superiority in terms of cardiovascular (CV) risk reduction. In addition, recent data showed that CTD was safe and effective in terms of BP lowering in p...
Source: Hellenic Journal of Cardiology - July 10, 2023 Category: Cardiology Authors: Anastasios Kollias Konstantinos G Kyriakoulis George S Stergiou Source Type: research
Retransplantation in Greece: Ethical and practical considerations
Hellenic J Cardiol. 2023 Jul 8:S1109-9666(23)00114-8. doi: 10.1016/j.hjc.2023.07.002. Online ahead of print.NO ABSTRACTPMID:37429504 | DOI:10.1016/j.hjc.2023.07.002 (Source: Hellenic Journal of Cardiology)
Source: Hellenic Journal of Cardiology - July 10, 2023 Category: Cardiology Authors: Evangelos Leontiadis Nektarios Kogerakis Angeliki Gkouziouta Socrates Fragoulis Areti Falara Dimitrios Zarkalis Loukas Tsourelis Michael Bonios Loukas Kaklamanis Dimitrios Degiannis Themistoklis Chamogeorgakis Theofani Antoniou Stamatis Adamopoulos Source Type: research
Chlorthalidone versus hydrochlorothiazide for preventing cardiovascular disease in hypertension: Is the case closed?
Hellenic J Cardiol. 2023 Jul 8:S1109-9666(23)00115-X. doi: 10.1016/j.hjc.2023.07.003. Online ahead of print.ABSTRACTThe optimal diuretic choice [hydrochlorothiazide (HCTZ) or chlorthalidone (CTD)] for the management of hypertension has been an ongoing debate for several years. HCTZ is widely used in the form of single-pill combinations, whereas CTD is a more potent drug vs. HCTZ, especially in reducing nighttime blood pressure (BP), with some indirect evidence suggesting a superiority in terms of cardiovascular (CV) risk reduction. In addition, recent data showed that CTD was safe and effective in terms of BP lowering in p...
Source: Hellenic Journal of Cardiology - July 10, 2023 Category: Cardiology Authors: Anastasios Kollias Konstantinos G Kyriakoulis George S Stergiou Source Type: research
